Analysis of functional renal allograft tolerance with single-dose rapamycin based induction immunosuppression

被引:13
|
作者
Goggins, WC
Fisher, RA
Dattilo, JB
Cohen, DS
Tawes, JW
Dattilo, MPM
Babcock, GF
Frede, SE
Wakely, PE
Posner, MP
机构
[1] VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DIV TRANSPLANT SURG,DEPT SURG,RICHMOND,VA 23298
[2] VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DIV TRANSPLANT SURG,DEPT PATHOL,RICHMOND,VA 23298
[3] UNIV CINCINNATI,DEPT SURG,SHRINERS BURN HOSP,CINCINNATI,OH 45267
关键词
D O I
10.1097/00007890-199701270-00023
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The induction of transplantation tolerance is one of the primary goals following solid organ transplantation. The combination of a single dose of rapamycin (RAPA) with a short course of cyclosporine (CsA) has been shown to induce transplantation tolerance in the nonfunctional rat heterotopic cardiac transplant model. The purpose of this study was to assess this effective induction protocol in a functional renal transplant model. Male ACI (RTI(a)) and Lewis (RTI(1)) rats were used as donor and recipients respectively. Allografts received a single RAPA dose of (1.5 mg/kg) combined with CsA (10 mg/kg) 12-14 hr prior 60 transplantation. CsA (5 mg/kg) mas given daily on days +1-+7. Untreated Lewis to Lewis isografts served as histological controls. Chimerism, assessed in recipient shin, and intragraft interleukin (IL) 10 expression was determined utilizing PCR and RT-PCR techniques respectively. Treated animals and isografts were sacrificed 120-130 days post transplant for functional and histological evaluation, Allografts (n=9) were functionally tolerant with serum creatinine (0.77+/-0.1 vs. 0.88+/-0.1; P=0.275), blood urea nitrogen (37.6+/-4.6 vs. 23.3+/-1.9; P=0.123), and 24 hr protein excretion (27.0+/-4.4 vs. 17.9+/-5.2; P=0.131) similar to single kidney ACI controls. Histologically, 45% (4/9) allografts were indistinguishable from isografts with no evidence of rejection, and were considered immunologically tolerant. Donor/recipient chimerism was not detected. All immunologically tolerant allografts had evidence of intragraft IL-10 expression. Rejecting allografts and isografts did not express intragraft IL-10. This study confirms the efficacy of pre-engraftment single-dose RAPA combined with CsA in inducing true immunologic tolerance in this stringent functional renal transplant model. The expression of intragraft IL-10 in tolerant recipients suggests a Th-2 shift as the mechanism of tolerance in this model.
引用
收藏
页码:310 / 314
页数:5
相关论文
共 50 条
  • [21] A Randomized, Doubleblind, Placebo-Controlled, Study of Single-Dose Rituximab as Induction in Renal Transplantation
    Tyden, Gunnar
    Genberg, Helena
    Tollemar, Jan
    Ekberg, Henrik
    Persson, Nils H.
    Tufveson, Gunnar
    Wadstrom, Jonas
    Gabel, Markus
    Mjornstedt, Lars
    TRANSPLANTATION, 2009, 87 (09) : 1325 - 1329
  • [22] A prospective study of induction and maintenance immunosuppression with rapamycin, Daclizumab, and corticosteroids and low dose tacrolimus in renal transplantation with immunologic monitoring.
    Vo, AA
    Bunnapradist, S
    Puliyanda, D
    Rodich, GS
    Toyoda, M
    Jordan, SC
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 366A - 366A
  • [23] RENAL ALLOGRAFT OUTCOMES IN LIVE DONOR RECIPIENTS ON TACROLIMUS BASED TRIPLE IMMUNOSUPPRESSION WITH AND WITHOUT BASILIXIMAB INDUCTION
    Sakhuja, Vinay
    Gundlapalli, Srikanth
    Rathi, Manish
    Jha, Vivekanand
    Kohli, H. S.
    Sharma, Ashish
    Minz, M.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 513 - 513
  • [24] Management of the Failing Renal Allograft: A Single Center Analysis of Immunosuppression, Transfusions, Rejections and Transplant Nephrectomies
    Singh, P.
    Verma, S. R.
    Gorn, C. M.
    Harach, M.
    Herman, J. H.
    Colombe, B. W.
    Ramirez, C. B.
    Doria, C.
    Bodzin, A. S.
    Gulati, R.
    Francos, G. C.
    Maley, W. R.
    Frank, A. M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 491 - 491
  • [25] Renal Allograft Molecular Pathways Associated with Tolerance Induction in Renal Transplantation.
    Gallon, L.
    Mathew, J.
    Bontha, S.
    Dumur, C.
    Dalal, P.
    Nadimpalli, L.
    Maluf, D.
    Shetty, A.
    Ildstad, S.
    Leventhal, J.
    Mas, V.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 620 - 620
  • [26] SINGLE-DOSE PHARMACOKINETICS OF CEFPIROME IN PATIENTS WITH RENAL IMPAIRMENT
    LAMEIRE, N
    MALERCZYK, V
    DREES, B
    LEHR, K
    ROSENKRANZ, B
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 52 (01) : 24 - 30
  • [27] Effects of renal impairment on single-dose pharmacokinetics of entecavir
    Yan, JH
    Bifino, M
    Xie, J
    Freund, J
    Rahim, S
    Zhang, D
    Grasela, D
    LaCreta, F
    JOURNAL OF HEPATOLOGY, 2005, 42 : 195 - 195
  • [28] Single-dose pharmacokinetics of felbamate in patients with renal dysfunction
    Glue, P
    Sulowicz, W
    Colucci, R
    Banfield, C
    Pai, S
    Lin, C
    Affrime, MB
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 44 (01) : 91 - 93
  • [29] Pharmacokinetics of single-dose reboxetine in volunteers with renal insufficiency
    Coulomb, F
    Ducret, F
    Laneury, JP
    Fiorentini, F
    Poggesi, I
    Jannuzzo, MG
    Fleishaker, JC
    Houin, G
    Duchêne, P
    JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 40 (05): : 482 - 487
  • [30] EFFECTS OF SINGLE-DOSE DDC ON RENAL-FUNCTION
    LUKE, DR
    MASSARELLA, JW
    BELL, N
    DENNIS, S
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (02) : 136 - 136